Galapagos | GLPG - Ebitda

Prix De L'Action
28.82
Variation Quotidienne
0.20 0.70%
Mensuellement
2.27%
Annuel
17.06%
Q1 Prévisions
27.72




Ebitda Changement Date
argenx SE USD 387.05M 99.02M 2025-09
AstraZeneca USD 5.23B 272M 2025-09
Biogen USD 573.2M 253.7M 2025-12
Genmab DKK 477M 101M 2025-09
Gilead Sciences USD 4.03B 628M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
GRIFOLS EUR 347.24M 58.35M 2025-06
Hikma Pharmaceutical USD 369M 84M 2024-12
Incyte USD 414.5M 92.42M 2025-12
Merck EUR 1.71B 244M 2025-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Novartis USD 5.88B 290M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 4.84B 2.95B 2025-09
UCB EUR 1.03B 334M 2025-06
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09